Malaria: Progress, perils and prospects for eradication (Apr 2008) | BCH-VLR-SCBD-103485 | Biosafety Virtual Library Resources | Biosafety Clearing-House

Loading...
  |  

Biosafety Virtual Library Resources (VLR)

last updated: 11 May 2012

General Information
Malaria: Progress, perils and prospects for eradication
EN
Brian M. Greenwood, David A. Fidock, Dennis E. Kyle, Stefan H.I. Kappe, Pedro L. Alonso, Frank H. Collins, Patrick E. Duffy
EN
The American Society for Clinical Investigation
EN
2008-04
EN
Journal of Clinical Investigation
EN
Copyright © 2008, The American Society for Clinical Investigation
EN
Access to the resource(s)
Information on the content of the resource
Abstract:

T here are still approximately 500 million cases of malaria and 1 million deaths from malaria each year. Yet recently, malaria incidence has been dramatically reduced in some parts of Africa by increasing deployment of anti-mosquito measures and new artemisinin-containing treatments, prompting renewed calls for global eradication. However, treatment and mosquito control currently depend on too few compounds and thus are vulnerable to the emergence of compound-resistant parasites and mosquitoes. As discussed in this Review, new drugs, vaccines, and insecticides, as well as improved surveillance methods, are research priorities. Insights into parasite biology, human immunity, and vector behavior will guide efforts to translate parasite and mosquito genome sequences into novel interventions.
EN
Keywords for facilitating searching for information in the clearing-houses

https://bch.cbd.int/onlineconferences/ra_guidance_references.shtml

Yes
No
No
No
Additional Information
Identifier (ISBN, ISSN, etc.)
doi:10.1172/JCI33996
Format
11 page PDF
Keywords and any other relevant information
Citation: J. Clin. Invest. 118:1266–1276 (2008).
EN